Lv51
1104 积分 2023-04-06 加入
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
25天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
25天前
已完结
Adverse effects of intravenous LNP-mediated mRNA therapy in clinical trials: a systematic review and meta-analysis
26天前
已完结
The characteristics and its contributing factors of refractory rheumatoid arthritis, view of the rheumatologists of China: results of a nationwide cross-sectional survey
27天前
已完结
Development and preliminary validation of a pain measure specific to neuropathic pain
1个月前
已完结
From data to decision: critical appraisal of the 2025 NeuPSIG review and recommendations on neuropathic pain treatments
2个月前
已完结
Safety and Efficacy of Combining Tagraxofusp (SL-401) with Azacitidine or Azacitidine and Venetoclax in a Phase 1b Study for CD123 Positive AML, MDS, or BPDCN
2个月前
已关闭
Epidemiological patterns of leukaemia in 184 countries: a population-based study
2个月前
已完结
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
2个月前
已完结
Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escape
2个月前
已完结
皖公网安备34019202002308
